These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21550467)

  • 1. Financing HPV vaccination in developing countries.
    Lancet; 2011 May; 377(9777):1544. PubMed ID: 21550467
    [No Abstract]   [Full Text] [Related]  

  • 2. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of vaccination against HPV in Israel.
    Ginsberg GM; Fisher M; Ben-Shahar I; Bornstein J
    Vaccine; 2007 Sep; 25(37-38):6677-91. PubMed ID: 17706844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinate boys as well as girls against HPV: it works, and it may be cost effective.
    Prue G
    BMJ; 2014 Jul; 349():g4834. PubMed ID: 25073786
    [No Abstract]   [Full Text] [Related]  

  • 8. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free school-based vaccination with HPV vaccine in a Japanese city.
    Fujiwara H; Suzuki M; Yoshinari T; Shiiya K
    Vaccine; 2011 Sep; 29(38):6441-2. PubMed ID: 21704106
    [No Abstract]   [Full Text] [Related]  

  • 11. Funding for vaccination.
    Feris JM; Garib Z
    Lancet; 1998 Aug; 352(9127):579-80. PubMed ID: 9716093
    [No Abstract]   [Full Text] [Related]  

  • 12. Market-based licensing for HPV vaccines in developing countries.
    Outterson K; Kesselheim AS
    Health Aff (Millwood); 2008; 27(1):130-9. PubMed ID: 18180488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.
    Biellik R; Levin C; Mugisha E; LaMontagne DS; Bingham A; Kaipilyawar S; Gandhi S
    Vaccine; 2009 Oct; 27(44):6203-9. PubMed ID: 19698808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strange financing of HPV vaccination of girls].
    Kardel T
    Ugeskr Laeger; 2008 Mar; 170(14):1167. PubMed ID: 18437783
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations.
    Wong LP
    Vaccine; 2009 Mar; 27(10):1622-7. PubMed ID: 19100803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study.
    Favato G; Baio G; Capone A; Marcellusi A; Costa S; Garganese G; Picardo M; Drummond M; Jonsson B; Scambia G; Zweifel P; Mennini FS
    Med Care; 2012 Dec; 50(12):1076-85. PubMed ID: 22922435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.